Vanguard Fiduciary Trust’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.41M Buy
491,103
+19,445
+4% +$340K ﹤0.01% 1973
2026
Q1
$9.04M Buy
+471,658
New +$10.2M ﹤0.01% 1771

Other funds holding TNDM

Vanguard Fiduciary Trust's TNDM Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Tandem Diabetes Care (TNDM) stake by 4.1% in Q2 2026, buying an estimated $340K and bringing the position to 491,103 shares worth $7.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

Vanguard Fiduciary Trust first reported a position in TNDM in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.04M in Q1 2026. 271 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Vanguard Fiduciary Trust held 491,103 shares of Tandem Diabetes Care worth $7.41M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 19,445 Tandem Diabetes Care shares in Q2 2026, an estimated $340K.
  • Tandem Diabetes Care made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1973 holding.
  • Vanguard Fiduciary Trust first reported a position in Tandem Diabetes Care in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Tandem Diabetes Care position peaked at $9.04M in Q1 2026.
  • 271 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.